Skip to content

Open calls · Research grant · Immunology and Microbiology

Strengthening Services to Prevent the Infectious Disease Consequences of Drug Use

Centers for Disease Control and Prevention · National Harm Reduction Technical Assistance and Syringe Services Program (SSP) Monitoring and Evaluation Funding Opportunity · CDC-RFA-PS-27-0239

Go to the funder’s page
Opens24 Mar 2027

Deadlines

  • 24 May 2027 Estimated deadline in 190 days

Time of day: 11:59 pm ET.

Who can apply

Where the work is done
United States
Who applies
An organisation

Money

Total budget
$82.5M
Expected awards
2

About the call

This NOFO aims to strengthen services to prevent the infectious disease consequences of drug use in high impact settings serving people who use drugs (PWUD) through two components. Component 1 will improve service data by conducting a biennial survey of high-impact settings that serve PWUD to document capacity, needs, access, and service gaps. It will also improve timely local data on infectious disease consequences of drug use and the use of infectious disease testing, treatment, and prevention services at high-impact settings through a biennial biobehavioral survey of PWUD. Component 2 will increase support the availability and use of infectious disease testing, treatment and prevention services in high-impact settings serving PWUD. Applicants may apply for Component 1, Component 2, or both. Expected outcomes include enhanced capacity nationally and locally to use data to improve infectious disease testing, treatment and prevention services among PWUD, increased PWUD testing for HBV, HCV, and HIV, increased PWUD with hepatitis C who initiated treatment, and increased PWUD with HIV who engaged in care and treatment. This NOFO is in alignment with CDC priorities.

Text from the funder (US federal government, public domain).

We sort calls into fields, career stages and countries automatically. Always check the conditions on the funder’s page before you apply.

Discussion

Applying too? Looking for partners? Ask here.